{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:44:33Z","timestamp":1776973473343,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11011-022-00967-w","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:03:31Z","timestamp":1648609411000},"page":"1465-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration"],"prefix":"10.1007","volume":"37","author":[{"given":"Romgase","family":"Sakamula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerapong","family":"Yata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-7339","authenticated-orcid":false,"given":"Wachiryah","family":"Thong-asa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/JN.S49207","volume":"2014","author":"OOE Abdel-Salam","year":"2014","unstructured":"Abdel-Salam OOE, Youness E, Khadrawy Y, Mohammed N, Sleem A (2014) Rotenone-induced nigrostriatal toxicity is reduced by methylene blue. J Neurorestoratol 2014:65\u201380","journal-title":"J Neurorestoratol"},{"issue":"1","key":"967_CR2","first-page":"23","volume":"68","author":"JA Badmus","year":"2011","unstructured":"Badmus JA, Adedosu TO, Fatoki JO, Adegbite VA, Adaramoye OA, Odunola OA (2011) Lipid peroxidation inhibition and antiradical activities of some leaf fractions of Mangifera indica. Acta Pol Pharm 68(1):23\u201329","journal-title":"Acta Pol Pharm"},{"key":"967_CR3","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","volume":"112","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan R, Vijayraja D, Mohankumar T, Manimaran D, Ganesan P, Choi DK, Elangovan N (2021) Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson\u2019s disease. J Chem Neuroanat 112:101890. https:\/\/doi.org\/10.1016\/j.jchemneu.2020.101890","journal-title":"J Chem Neuroanat"},{"key":"967_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball N, Teo W-P, Chandra S, Chapman J (2019) Parkinson\u2019s Disease and the Environment. Frontiers in neurology 10:218\u2013218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Frontiers in neurology"},{"issue":"1","key":"967_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","volume":"12","author":"A Beloqui","year":"2016","unstructured":"Beloqui A, Solin\u00eds M, Rodr\u00edguez-Gasc\u00f3n A, Almeida AJ, Pr\u00e9at V (2016) Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine 12(1):143\u2013161. https:\/\/doi.org\/10.1016\/j.nano.2015.09.004","journal-title":"Nanomedicine"},{"issue":"11","key":"967_CR6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1089\/jmf.2010.0238","volume":"14","author":"M Buelna-Chontal","year":"2011","unstructured":"Buelna-Chontal M, Correa F, Hern\u00e1ndez-Res\u00e9ndiz S, Zazueta C, Pedraza-Chaverri J (2011) Protective effect of \u03b1-mangostin on cardiac reperfusion damage by attenuation of oxidative stress. J Med Food 14(11):1370\u20131374. https:\/\/doi.org\/10.1089\/jmf.2010.0238","journal-title":"J Med Food"},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290. https:\/\/doi.org\/10.1016\/j.nbd.2009.01.016","journal-title":"Neurobiol Dis"},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"967_CR9","first-page":"504","volume":"40","author":"G De Maagd","year":"2015","unstructured":"De Maagd G, Philip A (2015) Parkinsons Disease and Its Management Part 1 Disease Entity Risk Factors Pathophysiology. Clin Present Diagnos P T a Peer Rev J Formula manage 40:504\u2013532","journal-title":"Clin Present Diagnos P T a Peer Rev J Formula manage"},{"key":"967_CR10","doi-asserted-by":"publisher","unstructured":"Do HTT, Cho J (2020) Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21176211","DOI":"10.3390\/ijms21176211"},{"issue":"5","key":"967_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/pharmaceutics12050451","volume":"12","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, Omar MM, Mahmoud HA, Abou-Taleb HA (2020) Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study. Pharmaceutics 14 12(5):451. https:\/\/doi.org\/10.3390\/pharmaceutics12050451","journal-title":"Pharmaceutics 14"},{"issue":"1","key":"967_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"967_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/18722105130105","volume":"7","author":"C Fang","year":"2012","unstructured":"Fang C, Al-Suwayeh S, Fang J-Y (2012) Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting. Recent Pat Nanotechnol 7(1):41\u201355. https:\/\/doi.org\/10.2174\/18722105130105","journal-title":"Recent Pat Nanotechnol"},{"key":"967_CR14","doi-asserted-by":"publisher","first-page":"21018","DOI":"10.1038\/srep21018","volume":"6","author":"Y Fang","year":"2016","unstructured":"Fang Y, Su T, Qiu X, Mao P, Xu Y, Hu Z, Liu Q (2016) Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci Rep 6:21018. https:\/\/doi.org\/10.1038\/srep21018","journal-title":"Sci Rep"},{"key":"967_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0006-8993(97)00008-5","volume":"753","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Schulz JB, Kowall NW, Beal MF (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res 753:157\u2013162. https:\/\/doi.org\/10.1016\/s0006-8993(97)00008-5","journal-title":"Brain Res"},{"key":"967_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/brb3.138","volume":"3","author":"CF Ferris","year":"2013","unstructured":"Ferris CF, Marella M, Smerkers B, Barchet TM, Gershman B, Matsuno-Yagi A, Yagi T (2013) A phenotypic model recapitulating the neuropathology of Parkinson\u2019s disease. Brain Behav 3:351\u2013366. https:\/\/doi.org\/10.1002\/brb3.138","journal-title":"Brain Behav"},{"key":"967_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","volume":"187","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Zhu C, Fernagut PO, Mehta A, DiCarlo CD, Seaman RL, Chesselet MF (2004) Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 187:418\u2013429. https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.023","journal-title":"Exp Neurol"},{"key":"967_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.dib.2015.12.012","volume":"6","author":"MH Hadwan","year":"2016","unstructured":"Hadwan MH, Abed HN (2016) Data supporting the spectrophotometric method for the estimation of catalase activity. Data Brief 6:194\u2013199. https:\/\/doi.org\/10.1016\/j.dib.2015.12.012","journal-title":"Data Brief"},{"key":"967_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/10286020.2017.1339349","volume":"19","author":"X-M Hao","year":"2017","unstructured":"Hao X-M, Li L-D, Duan C-L, Li Y-J (2017) Neuroprotective effect of \u03b1-mangostin on mitochondrial dysfunction and \u03b1-synuclein aggregation in rotenone-induced model of Parkinson\u2019s disease in differentiated SH-SY5Y cells. J Asian Nat Prod Res 19:833\u2013845. https:\/\/doi.org\/10.1080\/10286020.2017.1339349","journal-title":"J Asian Nat Prod Res"},{"issue":"1","key":"967_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40199-017-0191-z","volume":"25","author":"P Hassanzadeh","year":"2017","unstructured":"Hassanzadeh P, Atyabi F, Dinarvand R, Dehpour A, Azhdarzadeh M, Dinarvand M (2017) Application of nanostructured lipid carriers: The prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway. Daru 25(1):25. https:\/\/doi.org\/10.1186\/s40199-017-0191-z","journal-title":"Daru"},{"key":"967_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/pharmaceutics12100928","volume":"12","author":"S Hernando","year":"2020","unstructured":"Hernando S, Herran E, Hernandez RM, Igartua M (2020) Nanostructured Lipid Carriers Made of \u03a9-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases. Pharmaceutics 12:928. https:\/\/doi.org\/10.3390\/pharmaceutics12100928","journal-title":"Pharmaceutics"},{"key":"967_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","volume":"84","author":"GU H\u00f6glinger","year":"2003","unstructured":"H\u00f6glinger GU, F\u00e9ger J, Prigent A, Michel PP, Parain K, Champy P, Hirsch EC (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84:491\u2013502. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01533.x","journal-title":"J Neurochem"},{"key":"967_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.arabjc.2014.02.011","volume":"9","author":"MY Ibrahim","year":"2016","unstructured":"Ibrahim MY, Hashim NM, Mariod AA, Mohan S, Abdulla MA, Abdelwahab SI, Arbab IA (2016) \u03b1-Mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties. Arab J Chem 9:317\u2013329. https:\/\/doi.org\/10.1016\/j.arabjc.2014.02.011","journal-title":"Arab J Chem"},{"key":"967_CR24","doi-asserted-by":"publisher","first-page":"919058","DOI":"10.1155\/2015\/919058","volume":"2015","author":"P Janhom","year":"2015","unstructured":"Janhom P, Dharmasaroja P (2015) Neuroprotective Effects of Alpha-Mangostin on MPP+-Induced Apoptotic Cell Death in Neuroblastoma SH-SY5Y Cells. J Toxicol 2015:919058. https:\/\/doi.org\/10.1155\/2015\/919058","journal-title":"J Toxicol"},{"key":"967_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jchemneu.2015.11.002","volume":"70","author":"ME Johnson","year":"2015","unstructured":"Johnson ME, Lim Y, Senthilkumaran M, Zhou XF, Bobrovskaya L (2015) Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson\u2019s disease. J Chem Neuroanat 70:33\u201341. https:\/\/doi.org\/10.1016\/j.jchemneu.2015.11.002","journal-title":"J Chem Neuroanat"},{"key":"967_CR26","first-page":"1","volume":"3","author":"E Joseph","year":"2013","unstructured":"Joseph E, Saha R (2013) Advances in brain targeted drug delivery: Nanoparticulate systems. PharmaSciTech 3:1\u20138","journal-title":"PharmaSciTech"},{"key":"967_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bjbas.2016.07.001","volume":"5","author":"V Kumar","year":"2016","unstructured":"Kumar V et al (2016) \u03b1-Mangostin Mediated Pharmacological Modulation of Hepatic Carbohydrate Metabolism in Diabetes Induced Wistar Rat. Beni-seuf univ J Appl Sci 5:255\u2013276. https:\/\/doi.org\/10.1016\/j.bjbas.2016.07.001","journal-title":"Beni-seuf univ J Appl Sci"},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"A Khosa","year":"2018","unstructured":"Khosa A, Reddi S, Saha RN (2018) Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother 103:598\u2013613. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.055","journal-title":"Biomed Pharmacother"},{"key":"967_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","volume":"72","author":"CS Lee","year":"1996","unstructured":"Lee CS, Sauer H, Bjorklund A (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641\u2013653. https:\/\/doi.org\/10.1016\/0306-4522(95)00571-4","journal-title":"Neuroscience"},{"issue":"1","key":"967_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u201375. https:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6","journal-title":"J Biol Chem"},{"key":"967_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl Neurodegener 6:28. https:\/\/doi.org\/10.1186\/s40035-017-0099-z","journal-title":"Transl Neurodegener"},{"issue":"6","key":"967_CR32","doi-asserted-by":"publisher","first-page":"a009282","DOI":"10.1101\/cshperspect.a009282","volume":"2","author":"P Mazzoni","year":"2012","unstructured":"Mazzoni P, Shabbott B, Cortes J (2012) Motor Control Abnormalities in Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2(6):a009282. https:\/\/doi.org\/10.1101\/cshperspect.a009282","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"967_CR33","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247(10):3170\u20133175","journal-title":"J Biol Chem"},{"key":"967_CR34","doi-asserted-by":"publisher","unstructured":"Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M (2020) Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21093254","DOI":"10.3390\/ijms21093254"},{"key":"967_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/138161212798918995","volume":"18","author":"R Mythri","year":"2012","unstructured":"Mythri R, Bharath M (2012) Curcumin: A Potential Neuroprotective Agent in Parkinson\u2019s Disease. Curr Pharm Des 18:91\u201399. https:\/\/doi.org\/10.2174\/138161212798918995","journal-title":"Curr Pharm Des"},{"key":"967_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jneuroim.2016.05.008","volume":"297","author":"M Nava Catorce","year":"2016","unstructured":"Nava Catorce M, Acero G, Pedraza-Chaverri J, Fragoso G, Govezensky T, Gevorkian G (2016) Alpha-mangostin attenuates brain inflammation induced by peripheral lipopolysaccharide administration in C57BL\/6J mice. J Neuroimmunol 297:20\u201327. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.05.008","journal-title":"J Neuroimmunol"},{"key":"967_CR37","doi-asserted-by":"publisher","first-page":"134652","DOI":"10.1016\/j.neulet.2019.134652","volume":"716","author":"A Parkhe","year":"2019","unstructured":"Parkhe A, Parekh P, Nalla L, Sharma N, Sharma M, Gadepalli A, Khairnar A (2019) Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson\u2019s disease. Neurosci Lett 716:134652","journal-title":"Neurosci Lett"},{"issue":"11","key":"967_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1080\/10715760903214447","volume":"43","author":"JM P\u00e9rez-Rojas","year":"2009","unstructured":"P\u00e9rez-Rojas JM, Cruz C, Garc\u00eda-L\u00f3pez P, S\u00e1nchez-Gonz\u00e1lez DJ, Mart\u00ednez-Mart\u00ednez CM, Ceballos G, Espinosa M, Mel\u00e9ndez-Zajgla J, Pedraza-Chaverri J (2009) Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative\/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 43(11):1122\u20131132. https:\/\/doi.org\/10.1080\/10715760903214447","journal-title":"Free Radic Res"},{"key":"967_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainresbull.2015.02.007","volume":"113","author":"A Rahimmi","year":"2015","unstructured":"Rahimmi A, Khosrobakhsh F, Izadpanah E, Moloudi MR, Hassanzadeh K (2015) N-acetylcysteine prevents rotenone-induced Parkinson\u2019s disease in rat: An investigation into the interaction of parkin and Drp1 proteins. Brain Res Bull 113:34\u201340. https:\/\/doi.org\/10.1016\/j.brainresbull.2015.02.007","journal-title":"Brain Res Bull"},{"key":"967_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11481-018-9808-3","volume":"14","author":"SB Rangasamy","year":"2019","unstructured":"Rangasamy SB, Dasarathi S, Pahan P, Jana M, Pahan K (2019) Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson\u2019s Disease. J Neuroimmune Pharmacol 14:173\u2013187. https:\/\/doi.org\/10.1007\/s11481-018-9808-3","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"967_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.17219\/acem\/63999","volume":"26","author":"EB Romuk","year":"2017","unstructured":"Romuk EB, Szczurek W, Ole\u015b M, Gabrysiak A, Skowron M, Nowak P, Birkner E (2017) The evaluation of the changes in enzymatic antioxidant reserves and lipid peroxidation in chosen parts of the brain in an animal model of Parkinson disease. Adv Clin Exp Med 26(6):953\u2013959","journal-title":"Adv Clin Exp Med"},{"key":"967_CR42","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s12035-018-1256-9","volume":"56","author":"MF Salvatore","year":"2019","unstructured":"Salvatore MF, McInnis TR, Cantu MA, Apple DM, Pruett BS (2019) Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency. Mol Neurobiol 56:2728\u20132740. https:\/\/doi.org\/10.1007\/s12035-018-1256-9","journal-title":"Mol Neurobiol"},{"issue":"6","key":"967_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jbt.20199","volume":"21","author":"PD Sampath","year":"2007","unstructured":"Sampath PD, Vijayaraghavan K (2007) Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 21(6):336\u2013339. https:\/\/doi.org\/10.1002\/jbt.20199","journal-title":"J Biochem Mol Toxicol"},{"key":"967_CR44","doi-asserted-by":"publisher","unstructured":"Soderstrom KE, Baum G, Kordower JH (2010) Animal Models of Parkinson's Disease Handbook of the Neuroscience of Aging:551\u2013560 https:\/\/doi.org\/10.1016\/B978-008045046-9.00522-2","DOI":"10.1016\/B978-008045046-9.00522-2"},{"key":"967_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.neuroscience.2012.06.021","volume":"220","author":"M Sonia Angeline","year":"2012","unstructured":"Sonia Angeline M, Chaterjee P, Anand K, Ambasta RK, Kumar P (2012) Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat. Neuroscience 220:291\u2013301. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.06.021","journal-title":"Neuroscience"},{"key":"967_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2014.11.002","volume":"279","author":"C von Wrangel","year":"2015","unstructured":"von Wrangel C, Schwabe K, John N, Krauss JK, Alam M (2015) The rotenone-induced rat model of Parkinson\u2019s disease: behavioral and electrophysiological findings. Behav Brain Res 279:52\u201361","journal-title":"Behav Brain Res"},{"key":"967_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/nsa.S243017","volume":"13","author":"N Wathoni","year":"2020","unstructured":"Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R, Muchtaridi M (2020) Nanoparticle Drug Delivery Systems for \u03b1-Mangostin. Nanotechnol Sci Appl 13:23\u201336. https:\/\/doi.org\/10.2147\/nsa.S243017","journal-title":"Nanotechnol Sci Appl"},{"key":"967_CR48","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10571-006-9053-9","volume":"26","author":"E Weihe","year":"2006","unstructured":"Weihe E, Depboylu C, Sch\u00fctz B, Sch\u00e4fer MK, Eiden LE (2006) Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol Neurobiol 26:659\u2013678. https:\/\/doi.org\/10.1007\/s10571-006-9053-9","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"967_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuro.2009.01.002","volume":"30","author":"YN Wu","year":"2009","unstructured":"Wu YN, Johnson SW (2009) Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons. Neurotoxicol 30(2):320\u20135. https:\/\/doi.org\/10.1016\/j.neuro.2009.01.002","journal-title":"Neurotoxicol"},{"key":"967_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","volume":"226","author":"L Yao","year":"2016","unstructured":"Yao L, Gu X, Song Q, Wang X, Huang M, Hu M, Gao X (2016) Nanoformulated alpha-mangostin ameliorates Alzheimer\u2019s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance. J Control Release 226:1\u201314. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.055","journal-title":"J Control Release"},{"key":"967_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2016.11.008","volume":"50","author":"PKK Yeung","year":"2017","unstructured":"Yeung PKK, Lai AKW, Son HJ, Zhang X, Hwang O, Chung SSM, Chung SK (2017) Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson\u2019s disease. Neurobiol Aging 50:119\u2013133. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.11.008","journal-title":"Neurobiol Aging"},{"key":"967_CR52","doi-asserted-by":"publisher","unstructured":"Yostawonkul J, Surassmo S, Namdee K, Khongkow M, Boonthum C, Pagseesing S, Yata T (2017) Nanocarrier-mediated delivery of \u03b1-mangostin for non-surgical castration of male animals. Scientific Reports 7. https:\/\/doi.org\/10.1038\/s41598-017-16563-3","DOI":"10.1038\/s41598-017-16563-3"},{"key":"967_CR53","doi-asserted-by":"publisher","unstructured":"Zhang Q-S, Heng Y, Mou Z, Huang J-Y, Yuan Y-H, Chen N-H (2017) Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. Acta pharmacologica Sinica 38. https:\/\/doi.org\/10.1038\/aps.2017.49","DOI":"10.1038\/aps.2017.49"},{"key":"967_CR54","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/aps.2017.49","volume":"16","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Guo H, Guo X, Ge D, Shi Y, Lu X, Zhang Q (2019) Involvement of Akt\/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson\u2019s Disease Models. Int J Environ Res Public Health 16:3811. https:\/\/doi.org\/10.1038\/aps.2017.49","journal-title":"Int J Environ Res Public Health"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-00967-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-00967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:17:32Z","timestamp":1652840252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-00967-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-00967-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-568670\/v1","asserted-by":"object"}]},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international and national guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors agree to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agree to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}